Explore 3 Stock Ideas & Industry Insights Download Free Report
Daily Change:-42.00p (down 2.14%) as of the latest session
Daily Change:-3.80p (down 1.03%) as of the latest session
Daily Change:-14.00p (down 0.83%) as of the latest session
Daily Change:-9.30p (down 1.84%) as of the latest session
Daily Change:+0.03p (up 0.02%) as of the latest session
Applied Nutrition plc (LSE:APN), the Liverpool-headquartered maker of protein powders, pre-workout supplements and diet gummies, has told investors it now expects to beat its own full-year revenue guidance, while agreeing to buy aManufacturingFacilityin upstate New York. The announcement, made on 1 June 2026, bundled …
Oxford Biomedica (LSE:OXB), the Oxford-based contract development andManufacturingorganisation (CDMO) known to the market as OXB, delivered a mixed message to investors on 7 August 2026. A half-year trading update showed the business signing new clients at its fastest pace on record, yet also confirmed …
PureTech Health (LSE:PRTC), the London-listed biotech known for founding and spinning out drug-discovery companies, has reached one of the most consequential moments in its history. Celea Therapeutics, the company PureTech created to develop deupirfenidone for idiopathic pulmonary fibrosis (IPF), has completed a $180 million …
Tristel plc (LSE:TSTL), the Cambridgeshire-based maker of chlorine dioxide disinfection products for endoscopes, ultrasound probes and other medical devices, has told shareholders it delivered another year of double-digit growth in the twelve months to 30 June 2026. A trading update released on 22 July …
Allergy Therapeutics (LSE:AGY), the Worthing-based maker of injectable allergy immunotherapies, has had an eventful year. Since December 2025 the AIM-listed group has reported clinical progress in both flagship allergen programmes, secured its first grass pollen product approval under Germany's dedicated regulatory pathway, and overhauled …
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…